Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (6): 682-684.DOI: 10.3969/j.issn.1673-8640.2021.06.022
Received:2020-06-22
Online:2021-06-30
Published:2021-06-30
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.06.022
| 抗菌药物 | MIC值 | 判定结果 |
|---|---|---|
| 青霉素 | 2 | 敏感 |
| 阿莫西林-克拉维酸 | 1 | 敏感 |
| 头孢曲松 | 0.5 | 敏感 |
| 头孢吡肟 | 1 | 敏感 |
| 美罗培南 | 0.5 | 中介 |
| 利福平 | ≤0.25 | 敏感 |
| 左氧氟沙星 | ≤0.5 | 敏感 |
| 复方磺胺甲噁唑 | 1 | 中介 |
| 克林霉素 | >2 | 耐药 |
| 红霉素 | >2 | 耐药 |
| 利奈唑胺 | 0.25 | 敏感 |
| 万古霉素 | 0.25 | 敏感 |
| 四环素 | 4 | 耐药 |
| 抗菌药物 | MIC值 | 判定结果 |
|---|---|---|
| 青霉素 | 2 | 敏感 |
| 阿莫西林-克拉维酸 | 1 | 敏感 |
| 头孢曲松 | 0.5 | 敏感 |
| 头孢吡肟 | 1 | 敏感 |
| 美罗培南 | 0.5 | 中介 |
| 利福平 | ≤0.25 | 敏感 |
| 左氧氟沙星 | ≤0.5 | 敏感 |
| 复方磺胺甲噁唑 | 1 | 中介 |
| 克林霉素 | >2 | 耐药 |
| 红霉素 | >2 | 耐药 |
| 利奈唑胺 | 0.25 | 敏感 |
| 万古霉素 | 0.25 | 敏感 |
| 四环素 | 4 | 耐药 |
| [1] | 胥少汀, 葛宝丰, 徐印坎. 实用骨科学[M]. 4版. 北京: 人民军医出版社, 2012. |
| [2] | 张天久, 俞松, 杨小红, 等. 儿童骨关节化脓性感染102例致病菌与耐药性分析[J]. 中华实用儿科临床杂志, 2017,32(10):756-758. |
| [3] | 刘仕哲, 付桂兵, 唐盛平. 儿童骨关节化脓性感染的细菌谱及耐药性分析[J]. 中国现代药物应用, 2019,13(16):11-14. |
| [4] |
GENO K A, GILBERT G L, SONG J Y, et al. Pneumococcal capsules and their types:past,present,and future[J]. Clin Microbiol Rev, 2015,28(3):871-899.
DOI URL |
| [5] |
MARTENS P, WORM S W, LUNDGREN B, et al. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited[J]. BMC Infect Dis, 2004,4:21.
DOI URL |
| [6] |
LYU S, HU H L, YANG Y H, et al. A systematic review about Streptococcus pneumoniae serotype distribution in children in mainland of China before the PCV13 was licensed[J]. Expert Rev Vaccines, 2017,16(10):997-1006.
DOI URL |
| [7] |
CHEN K, ZHANG X, SHAN W, et al. Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China:a systematic review and meta-analysis[J]. Hum Vaccin Immunother, 2018,14(6):1453-1463.
DOI URL |
| [8] |
PAI R, GERTZ R E, BEALL B, et al. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates[J]. J Clin Microbiol, 2006,44(1):124-131.
DOI URL |
| [9] |
BOGAERT D, DE GROOT R, HERMANS P W. Streptococcus pneumoniae colonisation:the key to pneumococcal disease[J]. Lancet Infect Dis, 2004,4(3):144-154.
DOI URL |
| [10] |
BAO Y, WANG Q, YAO K, et al. The changing phenotypes and genotypes of invasive pneumococcal isolates from children in Shenzhen during 2013-2017[J]. Vaccine, 2019,37(49):7248-7255.
DOI URL |
| [11] |
MOORE M R, LINK-GELLES R, SCHAFFNER W, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA:analysis of multisite,population-based surveillance[J]. Lancet Infect Dis, 2015,15(3):301-309.
DOI URL |
| [12] |
WIJAYASRI S, HILLIER K, LIM G H, et al. The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario,Canada,2007-2017[J]. PLoS One, 2019,14(12):e0226353.
DOI URL |
| [13] |
NAKANO S, FUJISAWA T, ITO Y, et al. Nationwide surveillance of paediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugated vaccine,2015-2017[J]. Vaccine, 2020,38(7):1818-1824.
DOI URL |
| [14] |
KADIOGLU A, WEISER J N, PATON J C, et al. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease[J]. Nat Rev Microbiol, 2008,6(4):288-301.
DOI URL |
| [15] |
UCHIYAMA S, CARLIN A F, KHOSRAVI A, et al. The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion[J]. J Exp Med, 2009,206(9):1845-1852.
DOI URL |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
